Convergent Genomics is a startup based in the United States.
Based in the United States, Convergent Genomics is a startup.
Convergent Genomics develops a non-invasive genomic urine test called UroAmp to detect, monitor, and predict bladder cancer risks with high accuracy using next-generation sequencing of urine DNA.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.